Abstract
Background: Psychiatric disorders affect millions globally, causing remarkable disability and healthcare burden. Pharmacological treatments persist central in management of these conditions.
Objective: This article finds the effectiveness, challenges, and progressing role of medication in psychiatric care.
Methods: A novel study of clinical trials, meta-analyses, and guidelines published between 2000 and 2023 was held, focusing on anti-depressants, anti-psychotics, mood stabilizers, and anxiolytics.
Results: Medications enhance symptom remission, relapse prevention, and quality of life, but adherence issues, side effects, and stigma hinder optimal results.
Conclusion: On the other hand, necessary medications attain their best results when contrast with psychotherapy, patient education, and holistic approaches. Future advances in precision psychiatry may improve personalized care.
Keywords: Psychiatric disorder, schizophrenia, disability, medications